Share-based Payment Arrangement, Expense in USD of PRECISION BIOSCIENCES INC from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
PRECISION BIOSCIENCES INC quarterly and annual Share-based Payment Arrangement, Expense history and change rate from Q2 2018 to Q3 2025.
  • PRECISION BIOSCIENCES INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,386,000, a 25% decline year-over-year.
  • PRECISION BIOSCIENCES INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $11,715,000, a 2.4% decline year-over-year.
  • PRECISION BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2024 was $12,604,000, a 10% decline from 2023.
  • PRECISION BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2023 was $14,040,000, a 27% decline from 2022.
  • PRECISION BIOSCIENCES INC annual Share-based Payment Arrangement, Expense for 2022 was $19,197,000, a 16% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

PRECISION BIOSCIENCES INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $11,715,000 $2,386,000 -$813,000 -25% 01 Jul 2025 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $12,528,000 $2,937,000 +$8,000 +0.27% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $12,520,000 $2,822,000 -$84,000 -2.9% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $12,604,000 $3,570,000 +$601,000 +20% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
Q3 2024 $12,003,000 $3,199,000 +$94,000 +3% 01 Jul 2024 30 Sep 2024 10-Q 03 Nov 2025 2025 Q3
Q2 2024 $11,909,000 $2,929,000 -$945,000 -24% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 $12,854,000 $2,906,000 -$1,186,000 -29% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025 2025 Q1
Q4 2023 $14,040,000 $2,969,000 -$1,567,000 -35% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $15,607,000 $3,105,000 -$2,028,000 -40% 01 Jul 2023 30 Sep 2023 10-Q 04 Nov 2024 2024 Q3
Q2 2023 $17,635,000 $3,874,000 -$1,264,000 -25% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 $18,899,000 $4,092,000 -$298,000 -6.8% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $19,197,000 $4,536,000 +$101,000 +2.3% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $19,096,000 $5,133,000 +$582,000 +13% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 $18,514,000 $5,138,000 +$1,242,000 +32% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023 2023 Q2
Q1 2022 $17,272,000 $4,390,000 +$758,000 +21% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $16,514,000 $4,435,000 +$581,000 +15% 01 Oct 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 $15,933,000 $4,551,000 +$842,000 +23% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $15,091,000 $3,896,000 +$778,000 +25% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $14,313,000 $3,632,000 +$527,000 +17% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $13,786,000 $3,854,000 +$1,233,000 +47% 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 $12,553,000 $3,709,000 +$1,218,000 +49% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2021 Q3
Q2 2020 $11,335,000 $3,118,000 +$839,000 +37% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q2
Q1 2020 $10,496,000 $3,105,000 +$1,556,000 +100% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q4 2019 $8,940,000 $2,621,000 01 Oct 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q3 2019 $2,491,000 +$2,199,000 +753% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2020 Q3
Q2 2019 $2,279,000 +$2,024,000 +794% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020 2020 Q2
Q1 2019 $1,549,000 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020 2020 Q1
Q3 2018 $292,000 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $255,000 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019 2019 Q2

PRECISION BIOSCIENCES INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $12,604,000 -$1,436,000 -10% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025 2024 FY
2023 $14,040,000 -$5,157,000 -27% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025 2024 FY
2022 $19,197,000 +$2,683,000 +16% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024 2023 FY
2021 $16,514,000 +$2,728,000 +20% 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2020 $13,786,000 +$4,846,000 +54% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $8,940,000 +$6,487,000 +264% 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021 2020 FY
2018 $2,453,000 01 Jan 2018 31 Dec 2018 10-K 10 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.